Respolin Autohaler New Zealand - English - Medsafe (Medicines Safety Authority)

respolin autohaler

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

Ventolin New Zealand - English - Medsafe (Medicines Safety Authority)

ventolin

glaxosmithkline nz limited - salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss);   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss)   excipient: norflurane - salbutamol is a selective ?2 adrenoceptor agonist indicated for the treatment or prevention of bronchospasm. it provides short acting (four hours) bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. for patients with asthma salbutamol may be used to relieve symptoms when they occur and to prevent them prior to a known trigger. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failure to respond promptly or fully to such rescue medication signals a need for urgent medical advice and treatment.

PHL-SALBUTAMOL RESPIRATOR SOLUTION Canada - English - Health Canada

phl-salbutamol respirator solution

pharmel inc - salbutamol (salbutamol sulfate) - solution - 0.5mg - salbutamol (salbutamol sulfate) 0.5mg - selective beta 2-adrenergic agonists

PHL-SALBUTAMOL RESPIRATOR SOLUTION Canada - English - Health Canada

phl-salbutamol respirator solution

pharmel inc - salbutamol (salbutamol sulfate) - solution - 1mg - salbutamol (salbutamol sulfate) 1mg - selective beta 2-adrenergic agonists

PHL-SALBUTAMOL RESPIRATOR SOLUTION Canada - English - Health Canada

phl-salbutamol respirator solution

pharmel inc - salbutamol (salbutamol sulfate) - solution - 2mg - salbutamol (salbutamol sulfate) 2mg - selective beta 2-adrenergic agonists

PHL-SALBUTAMOL RESPIRATOR SOLUTION Canada - English - Health Canada

phl-salbutamol respirator solution

pharmel inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists

PMS-SALBUTAMOL ORAL LIQUID SOLUTION Canada - English - Health Canada

pms-salbutamol oral liquid solution

pharmascience inc - salbutamol (salbutamol sulfate) - solution - 0.4mg - salbutamol (salbutamol sulfate) 0.4mg - selective beta 2-adrenergic agonists

PHL-SALBUTAMOL ORAL LIQUID SOLUTION Canada - English - Health Canada

phl-salbutamol oral liquid solution

pharmel inc - salbutamol (salbutamol sulfate) - solution - 0.4mg - salbutamol (salbutamol sulfate) 0.4mg - selective beta 2-adrenergic agonists

Respolin Autohaler New Zealand - English - Medsafe (Medicines Safety Authority)

respolin autohaler

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

RATIO-SALBUTAMOL SOLUTION Canada - English - Health Canada

ratio-salbutamol solution

teva canada limited - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists